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IT has been shown previously (Hartveit, 1961) that the adult mice used
at this Institute showeither a short survival time and a very haemorrhagic tumour
or a long survival time and a relatively asanguinous tumour, following the intra-
peritoneal injection of Ehrlich's ascites carcinoma. This negative correlation
between the survival time and the blood content ofthe tumour is not dependent on
the sex or weight of the mouse. As this tumour is said to grow progressively in
almost all strains ofmice (Karnofsky, 1953) it was decided to investigate the cause-
ofthis difference in survival time and blood content found in our mice.
In 1934 Apitz tested the theory that haemorrhage into the solid Ehrlich carci-
noma might be due to anaphylaxis, but he failed to produce haemorrhage by this
means. He also failed to produce haemorrhage as the result of treatment withi
histamine. Later Barrett (1942) investigated the relationship between anaphy-
laxis and sarcoma 37. He was able to show that the anaphylactic shock produced
in previously sensitized mice in response to horse serum was accompanied by
haemorrhage into actively growing transplants of this tumour. The reaction did
not occur in non-sensitized animals. He also produced haemorrhage into the
tumour in strain A mice in response to intraperitoneal histamine. The haemor-
rhagic reaction was not confined to the tumour but was also present, to a lesser
extent, in the stomach and small intestine. Barrett's experiment suggests that
haemorrhage into a tumour may be the result of the combination of a foreign
antigen with antibody present in the tumour.
The mice used in this Institute are heterozygous and also of different genetic
make-up from Ehrlich's ascites carcinoma. It was thought that their differences
in reaction to the tumour might represent different degrees of genetic difference,
and thus different degrees of resistance to the homotransplant.
Ludford (1931) and Andervont (1936) have shown that resistance to tumour
transplants can be abrogated by vital staining with trypan blue. More recentlv
many authors (reviewed by Toolan, 1953) have shown that it is possible for homo-
transplants to grow in animals treated with cortisone. The following experimenit
was planned in an attempt to reduce the resistance of inice to a tumour homo-
transplant (i.e. intraperitoneal Ehrlich's ascites carcinoma) by both the methods
mentioned above, to see if this treatment would influence the survival time ofthe
mice and the blood content of the tumour ascites.
MATERIAL AND METHODS
The mice used were taken from a closed colony ofpreviously inbred white mice.
All were adult, under 6 months old. The Ehrlich ascites carcinoma was originallyF. HARTVEIT
obtained from Professor Ahlstrom in Lund, and, at the time of the experiment,
was in its 70th transplant generation here.
Three groups of mice (I, II and III), each containing 15 males and 15 females,
were numbered 1-15 for each sex in each group; mice of the same sex and weight
(to the nearest gram) in each group receiving the same number. In this way the
mean starting weight of the animals in all 3 groups was the same, being 20-8 g.
(S.D. 1-237).
Each of the mice was given one intraperitoneal injection of 0-1 ml. of Ehrlich's
ascites carcinoma taken from a male mouse of the 70th transplant generation.
This mouse, which had received the tumour 10 days before, had 9-5 ml. of tumour
ascites which was slightly blood stained, with a tumour cell count of 2,050,000/cu.
mm. The cells all appeared viable, i.e. they did not take up eosin from a 1: 2,000
solution of eosin in Tyrode's solution (Schrek, 1936); they did not clump and
showed no abnormalities in films stained with haematoxalin and eosin. When the
injections were complete, about one hour after the donor mouse had been killed,
the tumour cells in the remaining fluid were all still viable.
Some of the mice were also given subcutaneous treatment as follows
Group I-the control group-received no subcutaneous treatment.
Group 11-the vitally stained group-were each given 0 5 ml. of a
0 5 per cent solution oftrypan blue in sterile distilled water, subcutaneously
on the back. The first injection of trypan blue was given 7 days before the
mice were injected with tumour ascites. The trypan blue injections were
repeated 2 and 4 days later, and thereafter weekly until all the mice in the
group were dead.
Group III-the cortisone treated group-received a suspension of
cortisone acetate as a subcutaneous injection on the back. The dose was
equivalent to 25 mg./kg. starting weight. The first injection was given 6
days before the mice were injected with tumour ascites. The cortisone
injections were repeated daily until all the mice in the group were dead.
Three additional control groups were set up (1, 2 and 3). Each of these groups
consisted of 5 male and 5 female mice of similar age and weight to those in the
three main groups. Each of these groups was given the same subcutaneous treat-
ment as the corresponding Roman figure group (i.e. none, trypan blue, and corti-
sone, respectively), but none ofthe mice were injected with tumour ascites.
The survival time ofeach mouse that died in every group was recorded. When
the mice in the Roman figure groups died the tumour ascites was removed and
1 ml. ofthis centrifuged at 2,400 r.p.m. for 45 minutes. The volume ofthered blood
cells at the bottom of the Wintrobe tube was taken as an estimate of the amount
ofblood present/ml. and recorded as a percentage ofthe total volume in the tube.*
RESULTS
Table I shows the sex difference in the survival time and blood content of the
tumour ascites in the mice ingroups I, I1 and III, all ofwhich died. The tablegives
the values for the total, male and female series, with the number ofmice, the mean
value with S.D., the S.E. of the actual difference between the male and female
means, and the t and P values for this difference.
* One mouse in group IL died of trauma the day after the iinjectiorn of the tumour and was
excluded from subsequent calculations.
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TABLE I.-The'Sex Differences in Survival Time and Blood Content of the Tumiour
Ascites in the Three Groups
x Group
I
Survival
time II
(days)
III
Blood
content
of
ascites
(vol. %) I
I
II {
III
Series
d+Y
-3 +9
d+Y
6'
Y
d+;
d+ SY
6'
n
30
15
15
29
14
15
30
15
15
30
15
15
29
14
15
30
15
15
£
]1-03
10-8
11*3
12-24
12-9
11*6
14-93
11*8
18-06
4-3
4-4
4-26
1-717
2-036
1 -53
1 - 216
0 9
1 *53
S.E.
difference
S.D.! F' & x
2- 683
2 186 } 1-013
3-253f
3- 332
2-901 a -3 4- 188 f
4- 528
3571 } 1-233
3-17 f
4- 638
51 } 1 736
4- 286
3 782 } 1 - 702
5-304 10
2-616
27569 } 09806
2-798
p
0-4862 . 0-7>P>0-6
0 9773 . 0-4>1'>0-3
5 077 (0001 >P
0 0806 . P>0 ')
0-2974 . 0-8>P-0 7
06424 . 0-6>P>0.5
The number of mice in each group anid series is shown, the mean value for the factor under con-
sideration (x) with its S.D., the S.E. of the? actual difference between male and female ineans, and the
and P values for this difference.
The mean survival time for the total series was shortest in the control group I
(11-03 days, S.D. 2-683), and longest in the cortisone treated group III (14-93 days,
S.D. 4-528). The vitally stained group II fell between these two extremes (12.24
days, S.D. 3-332). The sex difference within the groups was not statistically
significant in groups I and II (0-5 and 1-3 days respectively), while it was highly
significant in group III (6.26 days, 0-001 > P). The mean blood content of the
tumour ascites was highest in the control group 1 (4.3 per cent, S.D. 4-638), and
lowest in the cortisone treated group III (1-216 per cent, S.D. 2-616). Once
again the vitally stained group II showed an intermediate value (1.717 per cent,
S.D. 4-286). The sex differences were not significant.
TABLE Ila.-Comparison of the Differences in Survival Time Between the
Three Groups
Survival
tine
(days) 1,
Comparison
between
groups
x and y
I II
I III
I III
II III
II III
Series
d .
-
-
-
}'Ix
30
15
15
14
15
fly
29
15
15
15
15
Differ-
ence
between
x and y
1*21-
1.0
6-76
1-1
6-46
S.E.
difference
between
x and 1
0-7891
4-187
1-172
1*204
1i 356
t
0 1533
0 2388
5-768
0 9137
4-764
0 9>P>0 8
0 9>P>0 8
0-001>P
0*4>P>0*3
0-00l>P
The difference in survival time between the groups for the total series, or for the male and female
series separately when their difference is significant, is shown, with the number of mice used and the
S.E., t and P values for the difference.
Table Ila compares the differences in survival time between the three inain
groups, giving the difference between the groups for the total series, or for the male
41
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and female series separately when their difference is significant, with the number
of mice used, the S.E., t and P values for the difference.
The difference in survival time of the mice in groups I and II, total series
(1.21 days) is not statistically significant In groups I and III this difference (1 day)
is not significant for the male mice, but the difference for the female mice in these
groups (6.67 days) is highly significant (0.001 > P). The difference between
groups II and III for the male mice (11 days) is not significant, but that for the
females (6-46 days) is highly so (0-001 > P).
TABLE IIb.-Comparison of the Differences in Blood Content of the Tumour Ascites
Between the Three Groups
Comparison Differ- S.E.
between ence difference
groups between between
x and y Series nT n,il x and y x and y t P
Blood F I II 30 . 29 2-583 1-161 2-224 0-05>P>0-02
ascites I III 0+ . 30 30 . 3-184 . 09705 . 3-281 . 0O1>P>0 001
(vol %) t II III 29 30 . 0-501 . 0-7416 . 0675 0-5>P>0-4
The difference in blood content betweein the groups is showni for the total series, with the numnber
ofmice used, the S.E., t and P values for the difference.
Table Ilb compares the differences in blood content of the tumour ascites
betweenthe three main groups for the total series, giving the numberof miceused,
the S.E., t and P values for the difference. The difference between groups I and
11 (2-583 per cent) is significant (0-05 > P > 0-02), while that between groups I
and III (3-184 per cent) is highly so (0.01 > P > 0-001). The difference between
groups II and III (0-7416 per cent) is not significant.
The relationship between the survival time and the amount of blood in the
tumour ascites in the three main groups is shown in Table III, which gives the
TABLE III.-The Relationship Between the Survival Time and the Blood Content
ofthe Tumour Ascites in the Three Groups
Group Seties P, r S.E.r t P
f 30 0-8381 0-2397 . 3-496 0
.1 . 0-9831 0-2673 . 3-678 J l>P>0 001
15 -8708 0-2673 . 3-258
C + 29 . 0-5125 . 0-1889 2-713 . 0-02>P>0-01
II i d . 14 0-4658 0-2773 . 1-680 . ( 2>P>0-1
X .I.). - 0-7591 0-2673 . 2-840 0-02>P>0-01 6 (3+; . 30 - -0-01574 0-2397 0-06567 P>0-9 II.I5 .-0-02207 . 0-2673 . 0-08258 f
V .1.5 -0-02633. 0 2673. 0-9851 . 0 4>P>0 3
The number ofmice in each group and series is shown, and the correlation coefficielnt (r) with its S.E., t and P values.
number of mice in each group and series, the correlation coefficient (r), with its
S.E., t and P values. In the control group I the amount of blood in the tumour
ascites decreased with survival time. This negative correlation (- 0-8381, -0-9831,
-0-8708 for the total, male and female series, respectively) was highly significant
in all cases (0-01 > P > 0-001). These findings are in keeping with those in the
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author's previous experiment (Hartveit, 1961). In the vitally stained group II the
negative correlation was greatly reduced ( 0-5125, 0-4658, 0-7591, respective-
ly), being significant for the total and female series (0.02 > P > 0-01). It was
even further reduced in the cortisone treated group III (-0-01574, 0-02207,
--0.2633) and as such was not significant.
With regard to the control groups 1, 2 and 3; none ofthe miice in group 1 died.
One of the female mice in group 2 died 12 days after its first injection of trypan
blue. One male and one female mouse in group 3 died after 21 injections of corti-
sone.
DISCUSSION
In this experiment there are three factors to be considered: the tumour, the
relationship of the mice to the tumour and the interrelationship of the mice them-
selves.
As regards the tumour, Klein and Revesz (1953) have shown that provided a
sufficient tumour cell dose is used Ehrlich's ascites carcinoma can be expected to
grow progressively, and the mouse to die within a time limit dependent on that
tumour cell dose. The tumour cell dose used in the present experiment is compar-
able to that used in the author's previous experiment (Hartveit, 1961). The adult
mice were taken from the same closed colony. On comparing the mice in group I
of the present experiment to those in the previous experiment it is found that the
actual difference in their mean survival time (0.53 days) is not significant (0.5 > P
> 0-4). The difference in the mean blood content (1.7 per cent) is not significant
either (0.2 > P > 0.1). In both cases the negative correlation between the survival
time and the blood content of the tumour ascites is highly significant. Thus,
although the tumour canie from different transplant generations, there was no
significant difference in the survival time or blood content, and the relationship
between these two factors was unchanged. These facts support the view that the
tumour can, in this case, be regarded as a relatively constant factor. In the present
experiment all the tumour used came from one mouse, and this is an additional
safeguard to the assumption that the tumour is a constant.
The mice were, of necessity, of different genetic make-up to the tunmour, as
Ehrlich's ascites carcinoma came originally from a heterozygous mouse (Snell,
1953). Therefore, one would expect that the mice would not accept transplants.
But Ehrlich's ascites carcinoma is one of the so-called " non-specific " tumours
that is said to contain fewer antigens than usual and so is less demanding than
most in its choice of host (Barrett, 1958). However, a perfect fit between host and
tumour cannot be expected. While the fit may be close enough to allow the tumour
to grow the difference may show up in other ways-for example in the stromal
reaction.
Thus, although the mice were not, as in Barrett's experiment referred to earlier
(Barrett, 1942), sensitized beforehand with a foreign antigen, the tumour may
possess tissue antigens that the mice lack. If they then react against this foreign
protein their immunological response might be expected, on the basis of Barrett's
findings, to be accompanied by haemorrhage into the tumour, i.e. by a change in
the stromal reaction.
This hypothesis is based on the assumption that resistance to homotransplants
is genetically determined. This has been shown to be true in the case ofred blood
cells (Cushing and Campbell, 1957) and normal tissues (Loeb and Wright, 1927;
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Billingham, Brent, Medawar and Sparrow, 1954). The Mendelian nature of the
genetic influences determining susceptibility to transplanted tumours has also been
established (Little, 1956).
When a tumour is transplanted thetumnour cells reproduce, the stroma is
supplied by the host (Muir, 1951). In the case of Ehrlich's ascites carcinoma the
stroma is represented by the ascitic fluid, which contains a variable number of
white blood cells.In addition, in some cases, this stroma contains large numbers of
red blood cells (Loewenthal and Jahn, 1932; Kun, Talalay andWilliams-Ashman,
1951).
These red blood cells have appeared in the stronma either in direct response to
the tumour cells, or in response to the mouse's reaction to these cells. If the first
is the case we would expect that the amount of blood in the stroma would be
constant for a given tumnour cell dose. But the author has previously shown
(Hartveit, 1961) that the amount of blood varies inversely with the survival time
in micereceiving the same tumour cell dose. Ifthe second is then true, the amount
of blood should vary in accordance with the genetic dissimilarity between the
mouse and the tumour.
Genetic dissimilarity is evidenced as resistance to transplantation (Snell,
1957). It has been shown that this resistance can be abrogated (Ludford, 1931;
Andervont, 1936). The mice in the present experiment were treated in suChI a
way as to abrogate their resistance to the transplantation of foreign tissue.
On the basis of the above reasoning one would expect that by supressing host
resistance one would change the amount of blood present in the stroma: an
increase indicating that the blood was an expression of the mouse's lack of resis-
tance to the tumour, a decrease that it was an expression of its resistance. On the
basis of Barrett's experiment (Barrett, 1942), one would expect a decrease.
The mice used were heterozygous. This does not affect their individual rela-
tionship to the tumour as discussed above, but different degrees of reaction are to
be expected-those nearer to the tumour gentically reacting less against it. As
the mice were from the same closed colony it is reasonable to assume that the
genetic range in the three samples should be similar, and the results following
abrogation of their natural resistance comparable.
All the mice receiving Ehrlich's ascites carcinoma in the present experiment
were given the same dose of viable tumour cells. The dose used was chosen as it
was known to give an ascitic tumour and a relatively short survival time. The
dosage oftrypan blue was based on that used by Andervont (1936), and thecorti-
sone dosage on that used by Hobson (1960).
The results in the control mice show that the subcutaneous treatment alone
will not influence the survival times ofthe experimental groups to any appreciable
extent. Only one of the mice receiving trypan blue died during the course of the
experiment and two of those given cortisone died towards its end.
The results in groups I, II and III show that, although all the mice died, their
survival times and the blood content of their tumours differed considerably.
Trypan blue did not alter the survival time ofthe mice butit did reduce the amount
of blood in the tumour ascites. Cortisone increased the survival time ofthe female
mice, and greatly reduced the amount of blood in the ascites in both sexes. In
addition trypan blue, in part, and cortisone completely, abolished the negative
correlation between the survival time and the amount of blood in the tumour
ascites that was so strongly apparent in the control group.
670BLOOD CONTENT OF EHRLICH CARCINOMA
Thus, by using methods claimed to reduce the natural resistance of the mice
to tumour transplantation we have succeeded in increasing their survival time
and decreasing their stromal reaction to the tumour. The blood content of the
tumour must, therefore, be considered as an expression of resistance to Ehrlich's
ascites carcinoma. We are then left with the paradoxical situation in which the
mice with the greatest and most rapid local reaction to the tumour-indicating a
type of resistance-die before those without such resistance. Those dying early
died as a result of their immunological reaction to the homotransplant, while
those surviving longer died as a result of their acceptance of the tumour that was
able to grow progressively until it killed the host mechanically.
This finding that the blood content of the tumour is an expression of the
resistance ofthe mouse to the tumour may be ofpractical use in the field of tumour
immunity. In 1958 Barrett stated that antibodies "have eluded detection " in
this field. Since thern in vitro tests for haemagglutinins (Feldman and Sachs, 1957),
the tanned erythrocyte technique (Finney, Byers and Wilson, 1960), complement
fixation (Lund, 1958) and skin tests (Grace and Dao, 1958) have been reported to
give positive results. However, most evidence of such immunity is circumstantial.
Thus when an animal is immunized against a tumour the test of whether immunity
has been produced is whether or not a transplant of that tumour will be able to
grow in the host. Other methods involve the use of an immune serum from a
foreign host (Flax, 1956). In this case the antibody is an antibody to a foreign
protein, and is niot dependent on the fact that the cells were tumour cells. With
Ehrlich's ascites carcinoma the amount of blood in the ascites may prove to be a
yard-stick by which it will be possible to measure induced as well as natural
immunity to the tumour. Experiments in this direction are in progress.
It mayhe that this haemorrhagic reaction is a Shwartzman-like phenomenon.
It has been suggested that the Shwartzman phenomenon may be a manifestation
of an immune response (Thomas, 1954). Stetson (1955) has showin that injection of
bacterial endotoxin can elicit haemorrhage in skin areas previously prepared by
the intradermal injection of homologous or heterologous bacterial products, and
compares the reaction to that following the injection of tuberculin in specifically
sensitized rabbits. He postulates that both reactions involve a delayed type of
allergy, that is accompanied by focal (haemorrhagic) reactions, and systemic
reactions-following intraperitoneal injection of the endotoxin-that may be
fatal. Lawrence (1956) has drawn analogies between this type of delayed sensi-
tivity and homnograft rejection. In the present experiment it has been shown that
the haemorrhagic response occurring in some of the mice following transplantation
of the tumour is dependent on their natural resistance to the transplant. This
response can be likened to the Shwartzman phenomenon in that the mice were
previously sensitive to the transplant and showed focal haemorrhage, and a
severe systemic reaction leading to death, following a massive intraperitoneal
dose of the incompatible material.
SUMMARY
Three groups of 30 heterozygous mice were injected with Ehrlich's ascites
carcinoma. Two of the groups of animals were treated with trypan blue and corti-
sone, respectively, in an attempt to abrogate theirnatural resistance to the tumour.
The amount of blood in the tumour ascites was found to be less following these
treatments. (Average per cent: Control-4 3, trypan blue-17, cortisone-1-2).
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Thus the blood content of the tuimour ascites can be regarded as an expression of
the animal's reaction against, i.e. natural resistance to, the tumour. It was also
shown that the survival time of the mice that did not react was greater than that
of those which reacted against the tumour--suggesting that the latter died as a
result of their immunological reaction to an overwhelming dose of foreign tissue.
It is possible that this reaction is comparable to a Shwartzman-like phenomenon.
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